Specific clinical and hormonal features of the non-classical form of 21-hydroxilase deficiency in the children during the first year of life detected from the results of neonatal screening
https://doi.org/10.14341/probl201460323-29
Abstract
The non-classical form of 21-hydroxilase deficiency (21-OHD) has up to now been fairly well studied only in the patients of prepubertal and pubertal age as well as in the women of reproductive age. The advent of neonatal screening for congenital adrenal hyperplasia (CAD) made it possible to more frequently detect 21-OHD in the children during the first year of life. The domestic literature proposes no clinical and laboratory criteria for 21-OHD in the young children. The results of neonatal screening of 50 children presenting with elevated 17-hydroxyprogesterone (17-OHP) levels carried out in the period from 2011 to 2013 were used to form two groups of patients, one comprised of 20 children with verified 21-OHD (group 1), the other containing 30 "healthy" children showing the false-positive elevation of 21-OHD levels. All the patients underwent the comprehensive clinical and hormonal examination supplemented by the molecular-genetic analysis. The main criterion for the inclusion of children in group 1 was the presence of mutations in the CYP21 gene It was shown that determination of 21-OHD by tandem mass-spectrometry (TMS) including that in the framework of multisteroid analysis yields the most specific and accurate data in the children below one year of age; such analysis is indicated to all patients in whom the neonatal screening for congenital adrenal hyperplasia reveals the slightly elevated 17-OHP levels. The analysis for the group of patients with verified 21-OHD has demonstrated the absence of clinical and laboratory signs of adrenal insufficiency and/or hyperandrogenism in the children aged below 1 year.
About the Authors
T A Ionova
Endocrinology Research Centre, Moscow
Russian Federation
Russian Federation
A N Tyulpakov
Endocrinology Research Centre, Moscow
Russian Federation
Russian Federation
References
1. White PC, Speiser PW. Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency1. Endocr Rev. 2000;21(3):245-91. doi: 10.1210/edrv.21.3.0398
2. Speiser PW, White PC. Congenital Adrenal Hyperplasia. N Engl J Med. 2003;349(8):776-88. doi: 10.1056/NEJMra021561
3. New MI, Wilson RC. Steroid disorders in children: Congenital adrenal hyperplasia and apparent mineralocorticoid excess. Proceedings of the National Academy of Sciences. 1999;96(22):12790-7. doi: 10.1073/pnas.96.22.12790
4. Speiser PW, Dupont B, Rubinstein P, Piazza A, Kastelan A, New МI. High frequency of nonclassical steroid 21-hydroxylase deficiency. Am J Hum Genet. 1985;37(4):650-667.
5. Sherman SL, Aston CE, Morton NE, Speiser PW, New MI. A segregation and linkage study of classical and nonclassical 21- hydroxylase deficiency. Am J Hum Genet. 1988;42(6):830–838.
6. Baumgartner-Parzer SM, Nowotny P, Heinze G, Waldhäusl W, Vierhapper H. Carrier Frequency of Congenital Adrenal Hyperplasia (21-Hydroxylase Deficiency) in a Middle European Population. The Journal of Clinical Endocrinology & Metabolism. 2005;90(2):775-8. doi: 10.1210/jc.2004-1728
7. Fitness J, Dixit N, Webster D, Torresani T, Pergolizzi R, Speiser PW, et al. Genotyping of CYP21, Linked Chromosome 6p Markers, and a Sex-Specific Gene in Neonatal Screening for Congenital Adrenal Hyperplasia1. The Journal of Clinical Endocrinology & Metabolism. 1999;84(3):960-6. doi: 10.1210/jcem.84.3.5550
8. Schrijver I, Parajes S, Quinteiro C, Domínguez F, Loidi L. High Frequency of Copy Number Variations and Sequence Variants at CYP21A2 Locus: Implication for the Genetic Diagnosis of 21-Hydroxylase Deficiency. PLoS One. 2008;3(5):e2138. doi: 10.1371/journal.pone.0002138
9. Ионова Т.А., Тюльпаков А.Н. Анализ распространенности неклассической формы врожденной дисфункции коры надпочеников на примере популяции московской области. // Проблемы Эндокринологии. 2013;59(4):18-22. [Ionova TA, Tiul'pakov AN, Kalinenkova SG. The prevalence of the non-classical form of congenital adrenal hyperplasia as exemplified (by the population of the Moscow region). Probl Endokrinol (Mosk). 2013;59(4):18-22.] doi: 10.14341/probl201359418-22
10. Pang SY, Wallace MA, Hofman L, Thuline HC, Dorche C, Lyon IC, et al. Worldwide experience in newborn screening for classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Pediatrics. 1988;81(6):866-874.
11. Tajima T, Jun Nakae KF, Toyoura T, Shimozawa K, Kusuda S, Goji K, et al. Molecular Basis of Nonclassical Steroid 21-Hydroxylase Deficiency Detected by Neonatal Mass Screening in Japan. The Journal of Clinical Endocrinology & Metabolism. 1997;82(7):2350-6. doi: 10.1210/jcem.82.7.4094
12. Tajima T, Fujieda K, Nakae JUN, Mikami A, Cutler GB. Mutations of the CYP21 Gene in Nonclassical Steroid 21-Hydroxylase Deficiency in Japan. Endocr J. 1998;45(4):493-7. doi: 10.1507/endocrj.45.493
13. Shinagawa T, Horikawa R, Isojima T, Naiki Y, Tanaka T, Katsumata N. Nonclassic Steroid 21-Hydroxylase Deficiency due to a Homozygous V281L Mutation in CYP21A2 Detected by the Neonatal Mass-Screening Program in Japan. Endocr J. 2007;54(6):1021-5. doi: 10.1507/endocrj.K07-028
14. Kashimada K-i, Ono M, Onishi T, Koyama S, Toyoura T, Imai K, et al. Clinical Course of Patients with Nonclassical 21-hydroxylase Deficiency (21-OHD) Diagnosed in Infancy and Childhood. Endocr J. 2008;55(2):397-404. doi: 10.1507/endocrj.K07E-057
15. Дедов И.И., Петеркова В.А., Колесникова Г.С., Семичева Т.В., Карева М.А., Кузнецова Э.С., и др. Молекулярная диагностика классических форм врожденной дисфункции коры надпочечников (дефицита стероид-21-гидроксилазы) методом аллель-специфической полимеразной цепной реакции. // Молекулярная медицина. 2004;(2):60-64.
16. [Dedov II, Orlovsky IV, Kareva MA, Akzhigitova DA, Bateneva EI, Loskutova LA, et al. Molecular diagnosis of classic forms of congenital dysfunction of the adrenal cortex (deficiency of steroid 21-hydroxilase) by application of allele-specific polymerase chain reaction. Molecular Medicine 2004;(2):60-64.]
17. New MI, Lorenzen F, Lerner AJ, Kohn B, Oberfield SE, Pollack MS, et al. Genotyping Steroid 21-Hydroxylase Deficiency: Hormonal Reference Data*. The Journal of Clinical Endocrinology & Metabolism. 1983;57(2):320-6. doi: 10.1210/jcem-57-2-320
Review
For citations:
Ionova T.A., Tyulpakov A.N. Specific clinical and hormonal features of the non-classical form of 21-hydroxilase deficiency in the children during the first year of life detected from the results of neonatal screening. Problems of Endocrinology. 2014;60(3):23-29. (In Russ.) https://doi.org/10.14341/probl201460323-29
Views:
437
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
.jpg){kind=logo}
